Difference between revisions of "Team:BGU Israel"
Line 73: | Line 73: | ||
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Design" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/6/6b/Bgu_brush-pencil.png" alt=""></a></div></td> | <td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Design" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/6/6b/Bgu_brush-pencil.png" alt=""></a></div></td> | ||
− | <td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_IsraelResults"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/ | + | <td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_IsraelResults"><div align="center"><img src="https://static.igem.org/mediawiki/2015/b/b0/Bgu_brightness.png" alt=""></a></div></td> |
− | <!-- https://static.igem.org/mediawiki/2015/b/ | + | <!-- https://static.igem.org/mediawiki/2015/b/b9/BGU_home_icon_briefcase.png --> |
<td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Practices" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt=""></a></div></td> | <td style="border-style: hidden;"><a href="https://2015.igem.org/Team:BGU_Israel/Practices" ><div align="center"><img src="https://static.igem.org/mediawiki/2015/8/89/BGU_Rgb.png" alt=""></a></div></td> |
Revision as of 09:23, 16 September 2015
The Boomerang system:
Despite recent treatment advancements, cancer is still a major cause of mortality worldwide. One of the fundamental problems preventing the development of effective therapy is the difficulty to target cancer cells exclusively.
In Boomerang, we're engineering a genetic device based on a simple concept of AND logic gate: the activation of our CRISPR/Cas9-based system is dependent on the existence of two cancer-specific promoters that control the expression of Cas9 and gRNA, and the combination of these two will occur only in cancer cells. CRISPR/Cas9 system allows several applications of Boomerang: 1) disruption of genes essential for cancer survival; and 2) activation of suicide genes, or color proteins for cancer cell detection (e.g., for complete surgical removal).
Our system can be potentially designed according to unique characteristics of a patient's tumor, paving the way to personalized medicine. We hope that our strategy will change the approach to cancer treatments.
|
Follow us:
Address:
Ben Gurion 1, Beer Sheva 8410501, Israel
Mail: igembgu2015@gmail.com